Literature DB >> 9681345

Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

R Fink-Puches1, H P Soyer, A Hofer, H Kerl, P Wolf.   

Abstract

OBJECTIVE: To investigate the immediate and long-term effects of photodynamic therapy with delta-aminolevulinic acid (ALA-PDT) on superficial basal cell carcinomas (BCC) and superficial squamous cell carcinomas (SCC).
DESIGN: Retrospective study with 60 months of maximal follow-up.
SETTING: University-based hospital in Graz, Austria. PATIENTS: Forty-seven subjects with a total of 95 superficial BCC and 35 superficial SCC.
INTERVENTIONS: A compound of 20% delta-aminolevulinic acid was topically applied under an occlusive and light-shielding dressing before exposure to either UV-A or different wave bands of polychromatic visible light (full-spectrum visible light, >515, >570, or >610 nm). MAIN OUTCOME MEASURES: Primary tumor responses and recurrence rates in the long-term follow-up, as well as histological changes associated with ALA-PDT, were studied.
RESULTS: The complete primary response rate for all wave bands of light was 86% (82/95) for superficial BCC and 54% (19/35) for superficial SCC. There was no statistically significant difference among the response rates to the different wave bands of light. After a median follow-up of 19 months (range, 3-60 months) for BCC and 8 months (range, 3-47 months) for SCC, the overall recurrence rate was 44% (36/81) and 69% (11/16), respectively. At 36 months after therapy, the projected disease-free rate was 50% (95% confidence interval, 43%-57%) for BCC vs 8% (95% confidence interval, 7%-9%) for SCC (P<.001, log-rank test). Histopathologic studies revealed a significant increase of fibrosis in the dermis after ALA-PDT and appearance of a sharp border between fibrotic and nonfibrotic tissue. In 15 of 16 BCC examined, the border between fibrotic and nonfibrotic tissue was deeper in the dermis than the maximum tumor thickness before therapy (P<.001, Wilcoxon signed rank test). Similar histopathologic observations were made in SCC.
CONCLUSIONS: Our study revealed poor long-term cure rates for superficial BCC and SCC treated with topical ALA-PDT and visible light. The histopathologic observations showing remarkable fibrosis in the dermis indicated that the effect of ALA-PDT reached deeper than the initial depth of invasiveness of the neoplastic tissue, suggesting in turn that the poor long-term results of ALA-PDT cannot be explained by insufficient penetration of the therapy effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681345     DOI: 10.1001/archderm.134.7.821

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  15 in total

1.  Management of high-risk cutaneous squamous cell carcinoma.

Authors:  Lorraine Jennings; Chrysalyne D Schmults
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 2.  High-risk non-melanoma skin cancer of the head and neck.

Authors:  Stephen Y Lai; Randal S Weber
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

Review 3.  [Photodynamic therapy of cutaneous epithelial malignancies. An evidence-based review].

Authors:  A Sidoroff
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

Review 4.  Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology.

Authors:  Glynis Ablon
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

Review 5.  Advances in Topical Treatments of Cutaneous Malignancies.

Authors:  Yanci A Algarin; Anokhi Jambusaria-Pahlajani; Emily Ruiz; Vishal A Patel
Journal:  Am J Clin Dermatol       Date:  2022-09-28       Impact factor: 6.233

6.  Noninvasive Optical Imaging of UV-Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX Production.

Authors:  Kishore R Rollakanti; Sanjay Anand; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photochem Photobiol       Date:  2015-09-25       Impact factor: 3.421

Review 7.  Nonmelanoma skin cancer.

Authors:  Tri H Nguyen; Diana Quynh-Dao Ho
Journal:  Curr Treat Options Oncol       Date:  2002-06

Review 8.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Oculoplastic aspects of ocular oncology.

Authors:  C Rene
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

10.  Cutaneous squamous cell carcinoma of the head and neck.

Authors:  Vivek V Gurudutt; Eric M Genden
Journal:  J Skin Cancer       Date:  2011-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.